Skip to content
RKWD
ROCKWOOD RESEARCH · A CORPORATE FILINGS WEBSITE|STRAIGHT FROM THE SOURCE · SEC EDGAR|SPONSOREDYour message on this tape — bid on the Rockwood Ad Exchange · Rockwood Ad Exchange|
Rockwood Research
…

ENTX

Entera Bio Ltd.

Biological Products, (No Diagnostic Substances) · SIC 2836CIK 1638097Held by 2 tracked managersEDGAR filings ↗10-K/10-Q ↗

SHARE:XLINKEDINEMAIL
Revenue FY2025
$0.0M
Net Income FY2025
$(11.0M)
EPS (Basic, as reported)
$0.25
Net Margin FY2025
-27235.7%
ROE FY2025
-87.3%
Total Equity
$13.0M
Shares Out
174M
Business description

Entera Bio Ltd. — Biological Products, (No Diagnostic Substances). Figures are as reported in each year's original 10-K via SEC EDGAR XBRL company facts (FY2020–FY2025; structured XBRL data begins around 2008). Market-price metrics are not part of EDGAR data.

Annual (fiscal years, as reported)USD millions
i
default rows · click any row to chart itRevenue: 0 → 0
Revenue010000
Cost of revenue000000
Gross profit000000
Research & development(6)(7)(6)(5)(4)(6)
Selling, general & administrative————00
General & administrative(5)(6)(7)(4)(5)(6)
Total operating expenses(11)(12)(13)(9)(10)(12)
Operating income(11)(12)(13)(9)(10)(12)
Other income (expense), net000000
Pre-tax income(11)(12)(13)(9)(10)(11)
Income tax expense000000
Net income(11)(12)(13)(9)(10)(11)
EPS — basic—$0.47$0.45$0.31$0.25$0.25
EPS — diluted—$0.47$0.45$0.31$0.25$0.25
Shares outstanding — basic (M)—2629293846
Shares outstanding — diluted (M)—2629293846

Source: SEC EDGAR XBRL company facts — figures as reported in each period's original filing (structured data begins ~2008). EPS and other per-share figures are as reported and are not adjusted for later stock splits; a ⚑ marks a period where the reported share count changed by a large factor. Dollar figures in millions unless per-share. Line items a company never reports are omitted. Where a filer switched XBRL concepts, the successor concept is used and definitions can differ slightly (e.g. cash may include restricted cash; banks' revenue is net of interest expense; cost of revenue may exclude D&A; net income may be the amount available to common stockholders; debt issued/repaid may be net of issuance costs or include finance-lease obligations — each only where the original concept stopped being reported). Click a period header to open that period's source filing on EDGAR.